Top Cancer Treatment Centre in Gurgaon: Understanding Cancer Immunotherapy and Targeted Treatment
Cancer treatment has evolved considerably with advances in medical research, molecular diagnostics, immunology, and precision oncology. Although conventional treatments such as surgery, chemotherapy, and radiation therapy remain essential for many cancers, selected patients may also benefit from newer approaches such as immunotherapy and targeted therapy.
For patients and families searching for a Top cancer treatment centre in gurgaon, understanding these treatment options can help them have more informed discussions with their oncology team. The suitability of any treatment depends on the cancer type, stage, molecular characteristics, previous treatment, overall health, and other individual factors.
What Is Modern Cancer Treatment?
Modern oncology generally uses a combination of diagnostic information and treatment approaches to develop an individualized plan.
Depending on the cancer, treatment may involve:
Surgery
Chemotherapy
Radiation therapy
Immunotherapy
Targeted therapy
Hormonal therapy
Cellular therapy
Precision oncology
Supportive and palliative care
Not every patient needs all of these treatments.
The treatment strategy should be based on the patient's specific diagnosis and clinical circumstances.
What Is Cancer Immunotherapy?
Immunotherapy is a type of cancer treatment that helps the immune system recognize and attack cancer cells.
Cancer cells can sometimes a**** immune-system detection or suppress immune responses. Certain immunotherapies are designed to interfere with these mechanisms and help restore an anti-cancer immune response.
Immunotherapy has become an important treatment option for selected cancers.
However, it is not appropriate for every patient.
How Does Immunotherapy Work?
The immune system normally identifies and responds to abnormal cells.
Cancer cells can develop mechanisms that allow them to a**** immune detection.
Some immunotherapy medicines target immune checkpoints involved in regulating immune responses.
By blocking certain checkpoint pathways, these medicines can allow immune cells to remain active against cancer cells.
The exact mechanism depends on the specific immunotherapy being used.
What Are Immune Checkpoint Inhibitors?
Immune checkpoint inhibitors are one important category of cancer immunotherapy.
They target proteins involved in regulating immune activity.
Examples of checkpoint pathways include:
PD-1
PD-L1
CTLA-4
Blocking these pathways can enhance immune-system activity against certain cancers.
The suitability of checkpoint inhibitors depends on the cancer diagnosis and relevant clinical factors.
Which Cancers Can Be Treated With Immunotherapy?
Immunotherapy has applications across several cancer types.
Depending on the specific medicine and clinical indication, immunotherapy may be considered for cancers such as:
Lung cancer
Melanoma
Kidney cancer
Bladder cancer
Head and neck cancers
Certain breast cancers
Certain gastroin****inal cancers
Some blood cancers
Other selected malignancies
The availability and suitability of immunotherapy depend on the cancer and individual patient.
Why Biomarkers Matter for Immunotherapy
Some patients undergo biomarker ****ing before immunotherapy is recommended.
Depending on the cancer, doctors may evaluate markers such as:
PD-L1 expression
Microsatellite instability
Mismatch repair status
Tumour mutational burden
Other relevant biomarkers
The appropriate ****ing depends on the cancer type and clinical situation.
A biomarker result should always be interpreted by an experienced oncology team.
Immunotherapy Does Not Work for Every Patient
One of the most important things patients should understand is that immunotherapy is not universally effective.
Some patients respond very well, while others may have little or no response.
Treatment response can depend on:
Cancer type
Stage
Tumour biology
Biomarkers
Previous treatment
Immune-system characteristics
Overall health
This is why individualized evaluation is important.
Immunotherapy Can Be Used With Other Treatments
Depending on the cancer, immunotherapy may be used:
Alone
With chemotherapy
With radiation
With targeted therapy
Before surgery
After surgery
The combination depends on clinical evidence for that specific cancer.
Patients should ask their oncologist why a particular combination has been recommended.
Immunotherapy Side Effects
Because immunotherapy affects the immune system, side effects can sometimes result from immune activity against healthy tissues.
Possible effects may involve:
Skin
Digestive system
Liver
Lungs
Thyroid
Other endocrine organs
Symptoms vary from patient to patient.
Patients receiving immunotherapy should report new or unusual symptoms to their medical team promptly.
What Is Targeted Cancer Therapy?
Targeted therapy is designed to act on specific molecules, proteins, or biological pathways involved in cancer growth.
Some cancer cells depend on particular molecular abnormalities.
If ****ing identifies a relevant target, a targeted medicine may sometimes be considered.
This approach is closely associated with precision oncology.
How Is Targeted Therapy Different From Chemotherapy?
Chemotherapy generally affects rapidly dividing cells throughout the body.
Targeted therapy is designed to act more specifically on particular molecular characteristics.
However, targeted therapy does not mean that side effects are absent.
Targeted medicines can also cause significant adverse effects, and their use requires appropriate medical monitoring.
Why Molecular Testing Can Matter
A targeted treatment usually requires a relevant biological target.
Molecular ****ing can sometimes identify:
Mutations
Gene fusions
Amplifications
Receptor abnormalities
Other actionable alterations
The **** selected depends on the cancer.
Not every genetic alteration has an approved treatment.
What Is Precision Oncology?
Precision oncology uses information about a tumour's molecular and genetic characteristics to help guide treatment decisions.
It can combine:
Histopathology
Biomarker ****ing
Genomic profiling
Molecular diagnostics
Imaging
Clinical information
The goal is to identify treatment strategies that are appropriate for the individual cancer.
Dr. AV Cancer Institute describes precision oncology and molecular diagnostics as central components of its personalized cancer-care approach.
Next-Generation Sequencing in Cancer Care
Next-generation sequencing, or NGS, can examine multiple genes or genomic regions simultaneously.
In oncology, it may help identify molecular alterations that could potentially influence treatment.
Dr. AV Cancer Institute describes NGS and molecular profiling as part of its precision-oncology approach. (idrav.com)
However, NGS should not be viewed as a guarantee of finding a treatable mutation.
The results require expert interpretation.
What Happens After a Molecular Alteration Is Found?
Finding a mutation does not automatically mean that targeted treatment is appropriate.
The oncologist may consider:
Whether the alteration is clinically relevant
Whether an approved treatment exists
Whether the treatment is appropriate for the cancer type
Previous treatments
Patient's health
Potential benefits and risks
Availability of clinical trials
This is why molecular reports should be interpreted by experienced specialists.
Chemotherapy Still Has an Important Role
The development of immunotherapy and targeted treatment does not mean chemotherapy has become unnecessary.
Chemotherapy remains an important treatment for many cancers.
It may be used:
Before surgery
After surgery
With radiation
With immunotherapy
With targeted treatment
For advanced disease
Dr. AV Cancer Institute lists cytotoxic chemotherapy among its cancer-treatment services. (idrav.com)
Surgery and Systemic Therapy
Some patients receive systemic treatment before surgery.
This may help reduce tumour burden or address microscopic cancer cells.
Other patients undergo surgery first and then receive additional treatment depending on pathology and recurrence risk.
The sequence depends on the specific cancer.
Visit us - https://idrav.com/